🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Natarajan Muthusamy

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

ORCID: 0000-0002-0351-4504

Also affiliated with The Ohio State University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Optimizing extracellular vesicles’ isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant”.

Optimizing extracellular vesicles’ isolation from chronic lymphocytic leukemia patient plasma and cell line supernatant

JCI Insight(2021)10.1172/jci.insight.137937
N/A
0.269DataRank · unranked
5 citations

Emanuele Cocucci, Ellen J. Sass, Xiaokui Mo, Angela R. Blissett, Edward Calomeni +8 more

Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

UNC Libraries(2021)10.17615/vfd1-7m89
N/A
0DataRank · unranked
3 citations

Geoffrey R. Hill, Steven M. Devine, Jason A. Dubovsky, Samantha Jaglowski, Bruce R. Blazar +25 more

Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential

Cancers(2022)10.3390/cancers14235787
N/A
0DataRank · unranked
16 citations

John C. Byrd, Natarajan Muthusamy, Max Yano

ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia

Leukemia Research(2022)10.1016/j.leukres.2022.106872
N/A
0DataRank · unranked
3 citations

Chi‐Ling Chiang, Kevan Zapolnik, Jessica Nunes, Ann Ventura, Xiaokui Mo +9 more

Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma

Leukemia(2023)10.1038/s41375-023-02006-8
N/A
0DataRank · unranked
13 citations

Satishkumar Singh, Zijun Y. Xu‐Monette, Krysta M. Coyle, Laura K. Hilton, Evangelia Chavdoula +14 more

Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia

Nature Communications(2024)10.1038/s41467-024-48678-3
N/A
0DataRank · unranked
12 citations

Rakeb Tafesse, Charlene Mao, Matthew Purcell, Xiaokui Mo, Liwen Zhang +5 more

CLEAR: coverage-based limiting-cell experiment analysis for RNA-seq

Journal of Translational Medicine(2020)10.1186/s12967-020-02247-6
N/A
0DataRank · unranked
22 citations

Michael G. Sovic, Chi‐Ling Chiang, Eileen Hu, Jiyeon K. Denninger, Xi Chen +6 more

Second Generation Tiancimycin-Based Antibody–Drug Conjugates Enabled by Highly Efficient Semi-synthetic Approach Specifically Targeting B-Cell Malignancies

JACS Au(2025)10.1021/jacsau.5c00353
N/A
0DataRank · unranked
2 citations

Pankajavalli Thirugnanasambantham, Yuan Jin, Andrew D. Steele, Dobeen Hwang, Yanlong Jiang +8 more